focus -WSS

focus

author：hotspot 2025-09-05 15:35:10 - browse：9136

Is no one safe from the FTC? Has Pfizer bottomed out? And is biotech finally back?

We cover all that and more this week on “The Readout LOUD,” STAT’s biotech podcast. First, we delve into the fallout over the FTC’s move to block what looked like a humdrum biotech deal between Sanofi and Maze Therapeutics, a surprising twist that leaves an unanswered question. We also discuss the latest news in the life sciences, including Pfizer’s downbeat future, Vertex Pharmaceuticals’ next big thing, and a newly minted biotech VC with a very famous name.

For more on what we cover, here’s the FTC news; here’s more from Maze Therapeutics; here’s the Pfizer news; here’s the latest on Vertex; here’s the story behind its pain drug; here’s the Reed Jobs profile; here’s where you can find episodes of Color Code; here’s where you can subscribe to the First Opinion Podcast; and here’s where you can subscribe to our biotech newsletter, The Readout.

Be sure to sign up on Apple Podcasts, Spotify, Stitcher, TuneIn, or wherever you get your podcasts.

And if you have any feedback for us — topics to cover, guests to invite, vocal tics to cease — you can email [email protected].

Previous article： New Eli Lilly Alzheimer’s data poses Medicare coverage conundrum
Next article： Shifting the focus from loneliness to social health

explore

WSS

ASCO Daily Recap: Safety data from Novartis, survival from Pfizer

At ASCO, AstraZeneca reports strong data for breast cancer drug

WuXi Biologics beefs up its lobbying operation

Supreme Court to hear if Covid misinformation is protected speech

Oak Street deal isn't the answer to health care's woes

ASCO: AstraZeneca's Tagrisso greatly slowed some lung cancers

leisure time

focus

focus

Alkermes shareholders re

At ASCO, pharma leaders speak of advances in 'smart bomb' drugs

Walensky prepares to leave CDC — and Congress — behind

STAT series 'Denied by AI' wins major journalism prizes

Tori Bowie and the unacceptable rates of Black maternal death

WuXi Biologics execs register to lobby as Congress comes for the company

Dobbs anniversary: the lost opportunity of abortion as health care

Why H5N1 bird flu is keeping the CDC's top flu scientist awake

The Supreme Court will review a ruling striking down a domestic violence federal gun ban

Lilly’s weekly insulin works as well as daily products, new studies show

Wikipedia

FDA's Pazdur wants cancer trials to range beyond China alone

ASCO: Palliative care found as helpful given virtually as in person

Ripples from Flovent's discontinuation is killing children with asthma

Ultragenyx gene therapy for rare liver ailment succeeds in late

Free medical tuition alone isn't enough to close gaps in primary care

ASCO: AstraZeneca says CAR

knowledge

hotspot

explore

focus